# Low-Dose Weekly vs High-Dose Cisplatin

> **NCT03649048** · NA · RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 100 (estimated)

## Conditions studied

- Locally Advanced Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** High-Dose Cisplatin
- **DRUG:** Low-Dose Cisplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT03649048
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-11-05
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649048, "Low-Dose Weekly vs High-Dose Cisplatin". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03649048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
